Similarly, the administration of a probiotic product combined with omega-3 fatty acid showed to notably enhance the QOL index, decrease the levels of IL-6, and weakened the negative effects of chemotherapy in CRC patients in comparison to the control placebo group in which a significant increase in TNF-α and IL-6 was observed [64]. The gene discussed is IL6; the disease is colorectal carcinoma.